Concepedia

Susanne Haneder

SH

Statistics

Publications

2

Citations

72

H-Index

2

Active since

2021

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (Germany)

AstraZeneca (United States)

Susanne Haneder is an author at AstraZeneca (United Kingdom) specializing in cancer immunotherapy, cancer biomarkers, and oncology.

Publications per year

2021–2024

2

Publications

2

HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancer

Ansh Kapil, Andreas Spitzmüller, Nicolas Brieu et al. · Scientific Reports · 2024 · 42 citations · Full text

, , +17

Abstract PD6-01: Novel approach to HER2 quantification: Digital pathology coupled with AI-based image and data analysis delivers objective and quantitative HER2 expression analysis for enrichment of responders to trastuzumab deruxtecan (T-DXd; DS-8201), specifically in HER2-low patients

Mark Gustavson, Susanne Haneder, Andreas Spitzmueller et al. · Cancer Research · 2021 · 30 citations

, , +17

1–2 of 2